13 Psychiatric Drugs With Novel Mechanisms: A Timeline

Slideshow

Some speculate the pharmaceutical industry has virtually abandoned new drug development in neuroscience with a few exceptions. However, it should be noted that progress has been made.

Related Videos
brain depression
brain
Related Content
What does the recent FDA clearance of this treatment for adolescents mean for the future of MDD treatment?

NeuroStar TMS and the Future of MDD Treatment for Adolescents

April 18th 2024
Article
Blue Light Blockers: A Behavior Therapy for Mania

Blue Light Blockers: A Behavior Therapy for Mania

October 7th 2021
Podcast
From a look at record-high suicide rates to subspecialty shortages in psychiatry, here are highlights from the week in Psychiatric Times.

The Week in Review: April 8-12

April 13th 2024
Article
Blue Light, Depression, and Bipolar Disorder

Blue Light, Depression, and Bipolar Disorder

August 4th 2021
Podcast
“The selectivity of NBI-1070770 for the NMDA NR2B receptor may benefit patients with moderate to severe depression.”

First Patient Dosed in Phase 2 Clinical Trial of NBI-1070770 for MDD

April 3rd 2024
Article
MDD

ALTO-203 for Major Depressive Disorder and Anhedonia: Phase 2 Study Initiated

April 3rd 2024
Article
© 2024 MJH Life Sciences

All rights reserved.